# 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology

> **NCT00207298** · — · COMPLETED · sponsor: **British Columbia Cancer Agency** · enrollment: 39242 (actual)

## Conditions studied

- Brain Neoplasms
- Lung Neoplasms
- Lymphoma
- Melanoma
- Colorectal Neoplasms

## Interventions

- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT00207298
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 39242 (ACTUAL)
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00207298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00207298, "18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00207298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*